| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/15/1999 | WO1999017769A1 INDENO[1,2-c]-, NAPHTHO[1,2-c]- AND BENZO[6,7]CYCLOHEPTA[1,2-c]PYRAZOLE DERIVATIVES |
| 04/15/1999 | WO1999017743A1 Dosage forms having improved release properties |
| 04/15/1999 | WO1999017712A2 Tightening and/or reducing the size of body parts containing fat cells |
| 04/15/1999 | WO1999017610A1 Protein delivery by secretory gland expression |
| 04/15/1999 | WO1999011778B1 Antisense treatment of pulmonary hypertension |
| 04/15/1999 | WO1999008708A3 Method and food product for increasing muscle protein and reducing fat in animals |
| 04/15/1999 | WO1999007720A3 Process for the purification of acarbose, pharmaceutical composition containing same and its use for the treatment of diabetes |
| 04/15/1999 | WO1999004773A3 Method for inhibiting bone resorption |
| 04/15/1999 | WO1999002142A3 Novel composition comprising an ssri and a beta-blocker |
| 04/15/1999 | WO1998045322A3 Diagnosis method and reagents |
| 04/15/1999 | DE19744127A1 Neue Vitamin D-Derivate mit Cyclopropylringen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung sowie ihre Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with Cyclopropylringen in the side chains, processes and intermediates for their preparation and their use for the production of pharmaceuticals |
| 04/15/1999 | CA2306273A1 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 04/15/1999 | CA2305808A1 Amidocarboxylic acid derivatives |
| 04/15/1999 | CA2304803A1 Protein delivery by secretory gland expression |
| 04/15/1999 | CA2304565A1 Indeno[1,2-c]-, naphtho[1,2-c]- and benzo[6,7]cyclohepta[1,2-c]pyrazole derivatives |
| 04/15/1999 | CA2304354A1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 04/15/1999 | CA2304152A1 Novel vitamin d analogues |
| 04/15/1999 | CA2303449A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/15/1999 | CA2273274A1 Dosage forms having improved release properties |
| 04/14/1999 | EP0908456A1 Pyrazole derivatives, their preparation and their use in drugs |
| 04/14/1999 | EP0908105A1 Process for obtaining plant peptones with a high hydrolysis degree and applications thereof |
| 04/14/1999 | EP0907732A2 Polynucleotides encoding secreted proteins |
| 04/14/1999 | EP0907666A1 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications |
| 04/14/1999 | EP0907658A1 Neuropeptide y agonists |
| 04/14/1999 | EP0907633A1 New synthetic catechol derivatives, method for production and use thereof |
| 04/14/1999 | EP0907631A1 Inorganic ion receptor-active compounds |
| 04/14/1999 | EP0907360A1 Method for maintaining an existing level of body fat and/or body weight |
| 04/14/1999 | EP0698010B1 N-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents |
| 04/14/1999 | EP0679659B1 Cathepsin-l-specific inhibitor polypeptide |
| 04/14/1999 | EP0626952B1 Hypolipidaemic benzothiazepine compounds |
| 04/14/1999 | CN1214050A Human tumor necrosis factor delta and epsilon |
| 04/14/1999 | CN1214043A Benzyl(idene)-lactam derivatives, their prepn. and their use as selective (ant) agaonists of 5-ht1A-and/or 5-ht1D receptors |
| 04/14/1999 | CN1213967A Benzothiophenes, formulations containing same, and methods |
| 04/13/1999 | CA2005547C Derivatives of 1,7' (imidazo-(1,2-a)-pyridine)5'-(6'h)ones |
| 04/08/1999 | WO1999016752A1 β3-ADRENORECEPTOR AGONISTS, AGONIST COMPOSITIONS AND METHODS OF USING |
| 04/08/1999 | WO1999016745A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
| 04/08/1999 | WO1999016459A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | WO1999016458A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | WO1999016452A1 THERAPEUTICALLY EFFECTIVE 1α, 25-DIHYDROXYVITAMIN D3 ANALOGS |
| 04/08/1999 | WO1999016409A2 Gene therapy approaches to supply apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | WO1999016408A2 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | CA2305140A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
| 04/08/1999 | CA2304931A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | CA2304814A1 Gene therapy approaches to supply apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | CA2304805A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | CA2304056A1 Therapeutically effective 1.alpha., 25-dihydroxyvitamin d3 analogs |
| 04/07/1999 | EP0906910A1 Chromene derivatives and salts thereof, and pharmaceuticals containing the same |
| 04/07/1999 | EP0906759A1 Novel osteoblastic specific mitogenes: process for their preparation and drugs containing these compounds |
| 04/07/1999 | EP0906310A1 OXADIAZOLE BENZENESULFONAMIDES AS SELECTIVE $g(b) 3? AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY |
| 04/07/1999 | EP0906303A1 Ring-fused dihydropyranes, process for the preparation and use thereof |
| 04/07/1999 | EP0906276A1 Novel vitamin d analogues |
| 04/07/1999 | EP0906089A2 Buccal delivery system |
| 04/07/1999 | EP0742715B1 Oral liquid compositions containing paroxetine resinate |
| 04/07/1999 | EP0669824B1 Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension |
| 04/07/1999 | EP0647266B1 D-enzyme compositions and methods of their use |
| 04/07/1999 | CN1213307A Novel substituted imidazolium compounds |
| 04/07/1999 | CN1213306A Novel substituted imidazolium compounds |
| 04/07/1999 | CN1213305A Novel cycloalkyl substituted imidazolium compounds |
| 04/06/1999 | US5891878 Enzyme inhibitors of phosphodiesterase or tumor necrosis factor |
| 04/06/1999 | US5891855 Contacting with cardiac glycoside |
| 04/06/1999 | US5891674 The use of these sequences in the diagnosis, prevention, and treatment of cancer, inflammation, and disorders associated with insulin response. |
| 04/06/1999 | US5891437 Antigen associated with type I diabetes mellitus |
| 04/06/1999 | US5891435 Antidiabetic agents and antigens |
| 04/06/1999 | US5891430 Diabetogene rad: a type II diabetes specific gene |
| 04/01/1999 | WO1999015635A1 Human ste20-like stress activated serine/threonine kinase |
| 04/01/1999 | WO1999015529A1 MODULES OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 04/01/1999 | WO1999015525A1 Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them |
| 04/01/1999 | WO1999015504A1 4-phenyltetrahydrochinoline utilized as an inhibitor of the cholesterol ester transfer protein |
| 04/01/1999 | WO1999015500A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 04/01/1999 | WO1999015498A1 New npy antagonists |
| 04/01/1999 | WO1999015487A1 Benzyl-biphenyls and analogous compounds and the application thereof in order to treat arteriosclerosis and dyslipidaemia |
| 04/01/1999 | WO1999015189A1 Metal compounds, mixed or sulphated, as phosphate binders |
| 04/01/1999 | WO1999015167A2 Use of citrus limonoids and flavonoids as well as tocotrienols for the treatment of cancer |
| 04/01/1999 | WO1999015164A1 Amide derivatives for the treatment of diseases mediated by cytokines |
| 04/01/1999 | WO1999015155A1 Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient |
| 04/01/1999 | WO1998048785A3 Allelic polygene diagnosis of reward deficiency syndrome and treatment |
| 04/01/1999 | CA2304397A1 Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them |
| 04/01/1999 | CA2304274A1 Benzyl-biphenyls and analogous compounds and the application thereof in order to treat arteriosclerosis and dyslipidaemia |
| 04/01/1999 | CA2304202A1 Use of citrus limonoids and flavonoids as well as tocotrienols for the treatment of cancer |
| 04/01/1999 | CA2303528A1 New npy antagonists |
| 04/01/1999 | CA2302572A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 04/01/1999 | CA2300051A1 Amide derivatives for the treatment of diseases mediated by cytokines |
| 03/31/1999 | EP0905255A2 Process for the preparation of pharmaceutically active thiazolidine or oxazolidine compounds by a yeast reductase |
| 03/31/1999 | EP0905139A2 5 ring heterocyles, process for preparation, use as inhibitors of leukocyte adhesion and pharmaceutical preparations comprising them |
| 03/31/1999 | EP0905136A1 Tetrahydro gamma-carbolines |
| 03/31/1999 | EP0904079A1 Antidiabetic agents |
| 03/31/1999 | EP0904073A1 Zwitterionic compositions and methods as biological response modifiers |
| 03/31/1999 | EP0762886A4 Icam-1/lfa-1 short-chain peptides and method of using same |
| 03/31/1999 | CN1212622A Use of antagnoist of PPAR-alpha and PPAR-gamma for treatment of syndrom X |
| 03/31/1999 | CN1212620A Mercapto derivatives as inhibitors of cyclooxygenases |
| 03/31/1999 | CN1212605A Composition and its use as food supplement or for lowering lipids in serum |
| 03/31/1999 | CN1212255A Biphenylsulfonyl cyanamides, process for their preparation, and their use as medicament |
| 03/31/1999 | CN1212150A Method for decreasing LDL-cholesterol concentration and increasing HDL-cholesterol concentration in blood to reduce risk of athereosclerosis and vascular disease |
| 03/31/1999 | CN1042730C Method for preparing pyrazolopyridine compound |
| 03/31/1999 | CN1042721C Graphite rod containing trace elements for requirement of human body and its instrument |
| 03/30/1999 | US5889049 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators |
| 03/30/1999 | US5889045 Benzopyran compounds |
| 03/30/1999 | US5889037 Prevention, therapy tissue damage from lipid peroxidation |
| 03/30/1999 | US5889036 Prophylactic or therapeutic drug for renal diseases |
| 03/30/1999 | US5889002 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |